PKNOX2
geneOn this page
Summary
PKNOX2 (PBX/knotted 1 homeobox 2, HGNC:16714) is a protein-coding gene on chromosome 11q24.2, encoding Homeobox protein PKNOX2 (Q96KN3).
Homeodomain proteins are sequence-specific transcription factors that share a highly conserved DNA-binding domain and play fundamental roles in cell proliferation, differentiation, and death. PKNOX2 belongs to the TALE (3-amino acid loop extension) class of homeodomain proteins characterized by a 3-amino acid extension between alpha helices 1 and 2 within the homeodomain (Imoto et al., 2001 [PubMed 11549286]).
Source: NCBI Gene 63876 — RefSeq curated summary.
At a glance
- GWAS associations: 19
- Clinical variants (ClinVar): 59 total
- MANE Select transcript:
NM_001382323
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16714 |
| Approved symbol | PKNOX2 |
| Name | PBX/knotted 1 homeobox 2 |
| Location | 11q24.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000165495 |
| Ensembl biotype | protein_coding |
| OMIM | 613066 |
| Entrez | 63876 |
Gene structure
Transcript identifiers
Ensembl transcripts: 25 — 15 protein_coding, 7 protein_coding_CDS_not_defined, 2 retained_intron, 1 nonsense_mediated_decay
ENST00000298282, ENST00000526955, ENST00000527238, ENST00000530517, ENST00000531116, ENST00000531212, ENST00000532623, ENST00000557814, ENST00000558705, ENST00000558729, ENST00000559662, ENST00000561115, ENST00000561298, ENST00000561399, ENST00000878493, ENST00000878494, ENST00000878495, ENST00000878496, ENST00000878497, ENST00000878498, ENST00000878499, ENST00000878500, ENST00000920818, ENST00000920819, ENST00000950472
RefSeq mRNA: 19 — MANE Select: NM_001382323
NM_001382323, NM_001382324, NM_001382325, NM_001382326, NM_001382327, NM_001382328, NM_001382329, NM_001382330, NM_001382331, NM_001382332, NM_001382333, NM_001382334, NM_001382335, NM_001382336, NM_001382337, NM_001382338, NM_001382339, NM_001382340, NM_001382341
CCDS: CCDS41730
Canonical transcript exons
ENST00000298282 — 13 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001432054 | 125235045 | 125235115 |
| ENSE00001432959 | 125331819 | 125331925 |
| ENSE00002153508 | 125164751 | 125164776 |
| ENSE00002177190 | 125431166 | 125433389 |
| ENSE00003695059 | 125429012 | 125429088 |
| ENSE00003695303 | 125351284 | 125351392 |
| ENSE00003695322 | 125410196 | 125410325 |
| ENSE00003696880 | 125385551 | 125385722 |
| ENSE00003696931 | 125397874 | 125398062 |
| ENSE00003697988 | 125411746 | 125411865 |
| ENSE00003698674 | 125429963 | 125430141 |
| ENSE00003698731 | 125367846 | 125367985 |
| ENSE00003700979 | 125410779 | 125410876 |
Expression profiles
Bgee: expression breadth ubiquitous, 236 present calls, max score 89.81.
FANTOM5 (CAGE): breadth broad, TPM avg 7.3789 / max 300.8850, expressed in 739 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 117438 | 4.4718 | 624 |
| 117437 | 1.7061 | 536 |
| 117436 | 0.9318 | 424 |
| 117439 | 0.1398 | 61 |
| 117440 | 0.1294 | 64 |
Top tissues by expression
279 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| pigmented layer of retina | UBERON:0001782 | 89.81 | gold quality |
| sural nerve | UBERON:0015488 | 89.10 | gold quality |
| right frontal lobe | UBERON:0002810 | 88.40 | gold quality |
| primary visual cortex | UBERON:0002436 | 88.12 | gold quality |
| prefrontal cortex | UBERON:0000451 | 87.46 | gold quality |
| frontal cortex | UBERON:0001870 | 86.90 | gold quality |
| cartilage tissue | UBERON:0002418 | 86.34 | gold quality |
| neocortex | UBERON:0001950 | 86.32 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 86.19 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 85.66 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 85.63 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 85.44 | gold quality |
| tibialis anterior | UBERON:0001385 | 85.19 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 85.17 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 84.99 | gold quality |
| gastrocnemius | UBERON:0001388 | 84.98 | gold quality |
| occipital lobe | UBERON:0002021 | 84.92 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 84.80 | gold quality |
| cingulate cortex | UBERON:0003027 | 84.78 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 84.62 | gold quality |
| muscle of leg | UBERON:0001383 | 84.52 | gold quality |
| postcentral gyrus | UBERON:0002581 | 84.06 | gold quality |
| cerebral cortex | UBERON:0000956 | 83.97 | gold quality |
| muscle organ | UBERON:0001630 | 83.73 | gold quality |
| orbitofrontal cortex | UBERON:0004167 | 83.35 | gold quality |
| endothelial cell | CL:0000115 | 82.61 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 82.46 | gold quality |
| cortical plate | UBERON:0005343 | 82.42 | gold quality |
| parietal lobe | UBERON:0001872 | 82.34 | gold quality |
| quadriceps femoris | UBERON:0001377 | 82.11 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ENAD-17 | no | 109.58 |
| E-GEOD-111727 | no | 24.15 |
| E-ANND-3 | no | 4.77 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA0783.1 | PKNOX2 | TALE-type homeo domain factors |
JASPAR matrix evidence (PMIDs): PMID:25233378
Literature-anchored findings (GeneRIF, showing 6)
- This novel PKNOX-related protein may interact with PBX proteins and play a role in tissue-specific regulation of transcription. (PMID:11549286)
- Using data from several genomewide case-control studies, we identified a strong and significant association signal with a novel gene, PKNOX2, on chromosome 11 with the composite phenotype in European-origin women (PMID:21298047)
- We identified four new loci (PKNOX2, MYH13, PHF2, and GPC6) associated with formal thought disorder in schizophrenia. (PMID:22648509)
- PKNOX2 was significantly downregulated in Fanconi anemia cells compared to donors. (PMID:30515693)
- PKNOX2 is a tumor suppressor in gastric cancer by activation of IGFBP5 and p53 signaling pathways (PMID:30745575)
- PBX/Knotted 1 homeobox-2 (PKNOX2) is a novel regulator of myocardial fibrosis. (PMID:38644381)
Cross-species orthologs
10 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | pknox2 | ENSDARG00000055349 |
| mus_musculus | Pknox2 | ENSMUSG00000035934 |
| rattus_norvegicus | Pknox2 | ENSRNOG00000028856 |
| drosophila_melanogaster | exd | FBGN0000611 |
| drosophila_melanogaster | hth | FBGN0001235 |
| drosophila_melanogaster | vis | FBGN0033748 |
| drosophila_melanogaster | achi | FBGN0033749 |
| caenorhabditis_elegans | WBGENE00000443 | |
| caenorhabditis_elegans | WBGENE00006796 | |
| caenorhabditis_elegans | WBGENE00017690 |
Paralogs (13): MEIS3 (ENSG00000105419), PBX4 (ENSG00000105717), TGIF2 (ENSG00000118707), MEIS2 (ENSG00000134138), MEIS1 (ENSG00000143995), TGIF2LX (ENSG00000153779), PKNOX1 (ENSG00000160199), PBX3 (ENSG00000167081), TGIF2LY (ENSG00000176679), TGIF1 (ENSG00000177426), PBX1 (ENSG00000185630), MEIS3P2 (ENSG00000188013), PBX2 (ENSG00000204304)
Protein
Protein identifiers
Homeobox protein PKNOX2 — Q96KN3 (reviewed: Q96KN3)
Alternative names: Homeobox protein PREP-2, PBX/knotted homeobox 2
All UniProt accessions (5): E9PKL2, E9PQS4, E9PRB6, Q96KN3, H0YLX0
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Nucleus.
Similarity. Belongs to the TALE/MEIS homeobox family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q96KN3-1 | 1 | yes |
| Q96KN3-2 | 2 |
RefSeq proteins (19): NP_001369252, NP_001369253, NP_001369254, NP_001369255, NP_001369256, NP_001369257, NP_001369258, NP_001369259, NP_001369260, NP_001369261, NP_001369262, NP_001369263, NP_001369264, NP_001369265, NP_001369266, NP_001369267, NP_001369268, NP_001369269, NP_001369270 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001356 | HD | Domain |
| IPR008422 | KN_HD | Domain |
| IPR009057 | Homeodomain-like_sf | Homologous_superfamily |
| IPR032453 | PKNOX/Meis_N | Domain |
| IPR050224 | TALE_homeobox | Family |
Pfam: PF05920, PF16493
UniProt features (15 total): compositionally biased region 4, region of interest 4, sequence variant 2, chain 1, domain 1, splice variant 1, sequence conflict 1, DNA-binding region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96KN3-F1 | 61.38 | 0.24 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 113 (showing top):
BENPORATH_ES_WITH_H3K27ME3, TGACCTY_ERR1_Q2, CEBP_Q2, CAGCAGG_MIR370, AGGAGTG_MIR483, TGANTCA_AP1_C, GOMF_ACTIN_BINDING, ATAACCT_MIR154, GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS, GRYDER_PAX3FOXO1_TOP_ENHANCERS, BLALOCK_ALZHEIMERS_DISEASE_DN, GOMF_CYTOSKELETAL_PROTEIN_BINDING, chr11q24, GOMF_ACTIN_MONOMER_BINDING, MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (7): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), actin monomer binding (GO:0003785), actin filament binding (GO:0051015), sequence-specific double-stranded DNA binding (GO:1990837), DNA binding (GO:0003677), protein binding (GO:0005515), sequence-specific DNA binding (GO:0043565)
GO Cellular Component (6): nucleoplasm (GO:0005654), cytoplasm (GO:0005737), actin cytoskeleton (GO:0015629), microtubule cytoskeleton (GO:0015630), intercellular bridge (GO:0045171), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| actin binding | 2 |
| cytoskeleton | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription cis-regulatory region binding | 1 |
| protein-containing complex binding | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| DNA binding | 1 |
| nuclear lumen | 1 |
| intracellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
914 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PKNOX2 | HYLS1 | Q96M11 | 907 |
| PKNOX2 | DDX25 | Q9UHL0 | 903 |
| PKNOX2 | HOXB1 | P14653 | 759 |
| PKNOX2 | HOXB2 | P10913 | 757 |
| PKNOX2 | PBX1 | P40424 | 620 |
| PKNOX2 | PECR | Q9BY49 | 536 |
| PKNOX2 | KIAA0040 | Q15053 | 524 |
| PKNOX2 | MYBBP1A | Q9BQG0 | 496 |
| PKNOX2 | EGR2 | P11161 | 431 |
| PKNOX2 | SLC37A2 | Q8TED4 | 429 |
| PKNOX2 | CPAP | Q9HC77 | 423 |
| PKNOX2 | HMBOX1 | Q6NT76 | 421 |
| PKNOX2 | TBP | P20226 | 415 |
| PKNOX2 | SOX5 | P35711 | 406 |
| PKNOX2 | YY1 | P25490 | 401 |
IntAct
127 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PKNOX2 | PBX4 | psi-mi:“MI:0915”(physical association) | 0.670 |
| CCDC120 | AIP | psi-mi:“MI:0914”(association) | 0.640 |
| CCDC185 | PKNOX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PKNOX2 | PICK1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| VPS37C | PKNOX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ARFIP2 | PKNOX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MYO15B | PKNOX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MBD3 | PKNOX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PKNOX2 | DDA1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NRIP1 | PKNOX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CREBL2 | PKNOX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PKNOX2 | TSG101 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PKNOX2 | CSTF2T | psi-mi:“MI:0915”(physical association) | 0.560 |
| PKNOX2 | NUP58 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCDC196 | PKNOX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HGS | PKNOX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM110B | PKNOX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PKNOX2 | CTTNBP2NL | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCDC116 | PKNOX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| USHBP1 | PKNOX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SMARCD1 | PKNOX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| IQGAP1 | PKNOX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MCRS1 | PKNOX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FHL2 | PKNOX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PKNOX2 | PAAT | psi-mi:“MI:0915”(physical association) | 0.560 |
| NUP54 | PKNOX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PKNOX2 | TRIB3 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (52): PKNOX2 (Affinity Capture-MS), PKNOX2 (Affinity Capture-MS), PKNOX2 (Affinity Capture-MS), PKNOX2 (Affinity Capture-MS), PKNOX2 (Affinity Capture-MS), PKNOX2 (Affinity Capture-MS), PKNOX2 (Affinity Capture-RNA), PKNOX2 (Two-hybrid), PKNOX2 (Two-hybrid), PKNOX2 (Two-hybrid), PKNOX2 (Two-hybrid), PKNOX2 (Two-hybrid), PKNOX2 (Two-hybrid), PKNOX2 (Two-hybrid), PKNOX2 (Two-hybrid)
ESM2 similar proteins: A0A096MJY4, A0A8C0NGY6, A0A8I3PQN6, A1L1N5, A1ZAU8, A2BEA6, A2ICN5, A2VDZ3, A4IFD2, A4UTP7, D6C652, H2LBU8, O75030, O88368, P19484, P23899, P27889, P35680, P46936, P46937, P46938, P58462, Q02078, Q03365, Q03413, Q05041, Q06413, Q08874, Q1L8J7, Q2EJA0, Q2LE08, Q2MJT0, Q32NJ6, Q4VYR7, Q4VYS1, Q58NQ4, Q5R444, Q5R6L1, Q5RER5, Q5W1J5
Diamond homologs: A1YGI6, A6NDR6, A8K0S8, A8WL06, B7ZRT8, O00470, O04136, O14770, O22300, O42261, O46339, O65685, O70477, P41779, P41817, P46606, P48000, P48001, P48002, P48731, P53147, P54269, P55347, P56659, P56660, P56664, P56665, P56669, P70284, P78412, P78413, P78414, P78415, P79937, P81067, P81068, P97367, P97368, Q0E3C3, Q0J6N4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
59 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 49 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3166 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:125331926:G:GG | donor_gain | 1.0000 |
| 11:125351389:ACAGG:A | donor_loss | 1.0000 |
| 11:125351390:CAGGT:C | donor_loss | 1.0000 |
| 11:125351393:G:GG | donor_gain | 1.0000 |
| 11:125351394:T:A | donor_loss | 1.0000 |
| 11:125367840:CTGCA:C | acceptor_loss | 1.0000 |
| 11:125367841:TGCAG:T | acceptor_loss | 1.0000 |
| 11:125367842:GCA:G | acceptor_loss | 1.0000 |
| 11:125367843:CAGA:C | acceptor_loss | 1.0000 |
| 11:125367844:A:AG | acceptor_gain | 1.0000 |
| 11:125367844:A:C | acceptor_loss | 1.0000 |
| 11:125367845:G:GG | acceptor_gain | 1.0000 |
| 11:125367845:GA:G | acceptor_gain | 1.0000 |
| 11:125367982:ACAGG:A | donor_loss | 1.0000 |
| 11:125367983:CAG:C | donor_loss | 1.0000 |
| 11:125367984:AGG:A | donor_loss | 1.0000 |
| 11:125367985:GG:G | donor_loss | 1.0000 |
| 11:125367987:T:A | donor_loss | 1.0000 |
| 11:125385719:TCTGG:T | donor_loss | 1.0000 |
| 11:125385724:T:C | donor_loss | 1.0000 |
| 11:125397871:CAGAT:C | acceptor_loss | 1.0000 |
| 11:125397872:A:AG | acceptor_gain | 1.0000 |
| 11:125397872:A:T | acceptor_loss | 1.0000 |
| 11:125397872:AGAT:A | acceptor_gain | 1.0000 |
| 11:125397873:G:GG | acceptor_gain | 1.0000 |
| 11:125397873:GA:G | acceptor_gain | 1.0000 |
| 11:125397873:GAT:G | acceptor_gain | 1.0000 |
| 11:125397873:GATG:G | acceptor_gain | 1.0000 |
| 11:125398005:G:GT | donor_gain | 1.0000 |
| 11:125398006:A:T | donor_gain | 1.0000 |
AlphaMissense
3140 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:125367971:G:C | K71N | 1.000 |
| 11:125367971:G:T | K71N | 1.000 |
| 11:125367979:T:A | V74E | 1.000 |
| 11:125385552:C:G | H77D | 1.000 |
| 11:125385553:A:G | H77R | 1.000 |
| 11:125385554:C:A | H77Q | 1.000 |
| 11:125385554:C:G | H77Q | 1.000 |
| 11:125385559:T:A | L79H | 1.000 |
| 11:125385559:T:C | L79P | 1.000 |
| 11:125385561:T:C | F80L | 1.000 |
| 11:125385562:T:C | F80S | 1.000 |
| 11:125385562:T:G | F80C | 1.000 |
| 11:125385563:C:A | F80L | 1.000 |
| 11:125385563:C:G | F80L | 1.000 |
| 11:125385568:T:A | L82H | 1.000 |
| 11:125385568:T:C | L82P | 1.000 |
| 11:125385571:T:C | L83P | 1.000 |
| 11:125385571:T:G | L83R | 1.000 |
| 11:125385577:T:C | L85P | 1.000 |
| 11:125385580:T:A | L86Q | 1.000 |
| 11:125385580:T:C | L86P | 1.000 |
| 11:125385580:T:G | L86R | 1.000 |
| 11:125385591:T:C | C90R | 1.000 |
| 11:125385592:G:A | C90Y | 1.000 |
| 11:125385592:G:T | C90F | 1.000 |
| 11:125385593:T:G | C90W | 1.000 |
| 11:125385600:G:C | A93P | 1.000 |
| 11:125385636:T:C | F105L | 1.000 |
| 11:125385637:T:C | F105S | 1.000 |
| 11:125385637:T:G | F105C | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000001741 (11:125254965 G>A), RS1000003430 (11:125327860 G>A), RS1000005306 (11:125225496 G>A), RS1000025591 (11:125292415 C>T), RS1000031529 (11:125181333 T>C), RS1000034210 (11:125371975 T>C), RS1000057855 (11:125366843 A>T), RS1000058162 (11:125292687 G>T), RS1000071947 (11:125403431 G>C), RS1000085058 (11:125322218 G>A), RS1000088151 (11:125265242 G>A), RS1000097112 (11:125407001 A>C,G), RS1000101854 (11:125249143 T>C), RS1000107225 (11:125219754 T>C), RS1000112267 (11:125211549 A>C)
Disease associations
OMIM: gene MIM:613066 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
19 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000956_1 | Substance dependence | 7.000000e-08 |
| GCST001121_2 | Alcohol dependence | 1.000000e-06 |
| GCST001254_3 | Alcohol dependence | 8.000000e-06 |
| GCST001471_6 | Alcohol and nicotine co-dependence | 2.000000e-06 |
| GCST001549_1 | Formal thought disorder in schizophrenia | 4.000000e-07 |
| GCST001565_12 | Schizophrenia | 7.000000e-07 |
| GCST001762_6 | Obesity-related traits | 2.000000e-06 |
| GCST002711_7 | Sleep duration | 5.000000e-06 |
| GCST002775_7 | Alzheimer’s disease (survival time) | 8.000000e-06 |
| GCST002861_2 | Breast cancer (survival) | 1.000000e-09 |
| GCST003538_5 | Alcohol dependence symptom count | 2.000000e-06 |
| GCST003992_4 | Photic sneeze reflex | 1.000000e-10 |
| GCST004635_22 | Testicular germ cell tumor | 2.000000e-12 |
| GCST004751_15 | Serum uric acid levels in response to allopurinol in gout | 4.000000e-06 |
| GCST005359_19 | Disease progression in age-related macular degeneration | 5.000000e-06 |
| GCST005759_8 | Dimensional psychopathology (Social) | 4.000000e-07 |
| GCST006085_52 | Prostate cancer | 2.000000e-11 |
| GCST006979_234 | Heel bone mineral density | 6.000000e-15 |
| GCST011741_58 | LDL cholesterol levels in HIV infection | 9.000000e-06 |
EFO canonical traits (10, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004805 | formal thought disorder |
| EFO:0004626 | IGFBP-3 measurement |
| EFO:0000714 | survival time |
| EFO:0007835 | alcohol dependence measurement |
| EFO:0007887 | autosomal dominant compelling helio-ophthalmic outburst syndrome |
| EFO:0004761 | uric acid measurement |
| EFO:0008336 | disease progression measurement |
| EFO:0009100 | social domain measurement |
| EFO:0009270 | heel bone mineral density |
| EFO:0004611 | low density lipoprotein cholesterol measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
34 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, decreases expression, increases expression | 4 |
| mercuric bromide | affects cotreatment, decreases expression | 2 |
| Panobinostat | affects cotreatment, increases expression | 2 |
| Benzo(a)pyrene | increases methylation, affects methylation | 2 |
| p-Chloromercuribenzoic Acid | affects cotreatment, decreases expression | 2 |
| methylmercuric chloride | decreases expression | 1 |
| bisphenol A | affects methylation | 1 |
| 2,5,2’,5’-tetrachlorobiphenyl | decreases expression | 1 |
| sodium arsenite | increases expression | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| aflatoxin B2 | increases methylation | 1 |
| 4-aminophenylarsenoxide | affects binding, decreases reaction | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| entinostat | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression, increases expression | 1 |
| abrine | increases expression | 1 |
| dorsomorphin | increases expression, affects cotreatment, decreases expression | 1 |
| bisphenol S | decreases methylation, affects cotreatment, increases methylation | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Arsenic Trioxide | affects binding, decreases reaction | 1 |
| Fulvestrant | affects cotreatment, increases methylation | 1 |
| Acetaminophen | increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Calcitriol | decreases expression, affects cotreatment | 1 |
| Doxorubicin | decreases expression | 1 |
| Methapyrilene | increases methylation | 1 |
| Nickel | decreases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Testosterone | affects cotreatment, decreases expression | 1 |
Cellosaurus cell lines
3 cell lines: 3 embryonic stem cell
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_A5J8 | SEES3-1V human PKNOX2, clone1 | Embryonic stem cell | Male |
| CVCL_A5J9 | SEES3-1V human PKNOX2, clone2 | Embryonic stem cell | Male |
| CVCL_A5K0 | SEES3-1V human PKNOX2, clone3 | Embryonic stem cell | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): age-related macular degeneration, alcohol and nicotine codependence, alcohol dependence, drug dependence, estrogen-receptor negative breast cancer, testicular germ cell tumor